Tuesday, May 29, 2012

CRegal's Posts

What Factors Lead to a Prostate Cancer Recurrence? A HealthCentral Explainer

It’s estimated that 90 percent of prostate cancer cases remain dormant and do not require clinical attention.  However, when the cancer does show signs of growth, prostate cancer treatment generally is very effective.  Nearly 100 percent of men survive the cancer five years after diagnosis, after 10 years the survival rate is 98... Read moreChevron

Prostate Cancer Drug Zytiga Proves Effective in Trials

A new drug may offer another treatment option to men with advanced stages of prostate cancer.  While early-stage cancers can be monitored, but not necessarily acted on, advanced versions often require an  invasive procedure, either through surgery or radiation.  But the new drug, Zytiga, may provide an alternative to those... Read moreChevron

New Research Could Expose Causes of Arthritis: A HealthCentral Explainer

Three new studies may have shed some light on the causes of arthritis, and the pain and inflammation that accompany the condition.  More than 27 million Americans now suffer from osteoarthritis, so finding a biological source of the problem would help with early diagnosis and treatment.  (CDC, 2011).  Osteoarthritis is a... Read moreChevron

Newsletter Poll Question

Do you receive the MS newsletter here on HealthCentral.com?  Do you like it?   Currently, we publish once per month but are kicking around changing the schedule.  How often would you like to see it?   Please answer the poll and let us know what you think!   Thank you!

The PSA Test Controversy: A HealthCentral Explainer

  What is the PSA test?   Testing the amount of Prostate Specific Antigen (PSA) in the blood can help diagnose prostate cancer.  PSA is a protein in the blood produced by prostate cells; a dramatic rise in the amount of PSA can indicate problems with the prostate gland, including prostate cancer, enlarged prostate, prostatitis or... Read moreChevron